ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib

Specific tyrosine-kinase inhibitors (TKIs) are widely used for the treatment of non-small-cell lung cancers with anaplastic lymphoma kinase (ALK) translocations. However, most treated patients eventually develop resistance to the TKIs. The histological transformation into small cell carcinoma is wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiho, Taisuke, Nakajima, Takahiro, Iwasawa, Shunichiro, Yonemori, Yoko, Yoshino, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039243/
https://www.ncbi.nlm.nih.gov/pubmed/32110052
http://dx.doi.org/10.2147/OTT.S236706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039243/
https://www.ncbi.nlm.nih.gov/pubmed/32110052
http://dx.doi.org/10.2147/OTT.S236706

Ejemplares similares